If no improvement and you have risk factors for malabsorption, trial MIC B12 injections for 8 weeks
GLP-1s not found to increase risk of ischemic optic neuropathy Several observational studies have suggested that GLP-1 treatment in people with diabetes may increase the risk of non-arteritic anterior ischemic optic neuropathy (NAION), a condition that can cause blindness
Patients often report improvement in overall health and well-being after a few months of testosterone replacement therapy
Developed to target common skin conditions such as melasma and hyperpigmentation, Gluteq Oral Spray offers a unique sublingual delivery system
Advocate for Yourself If you believe that GLP-1 medications are the best option or you and your doctor is not on the same page, you can always seek a second opinion
As of July 1, patients only have to pay a $50 copay that does not count towards their deductible, out-of-pocket, or cost-sharing assistance